Jaekel, N., Schulze, S., Zahn, C., Wienke, A., Richter, M., Koschmieder, S., Griesshammer, M., Sockel, K., Herbst, R., Wickenhauser, C., Al-Ali, H. K. (2025). Fedratinib in combination with CC-486, an oral hypomethylating agent, in patients with accelerated phase myelofibrosis: Results from the phase I/II famy trial. Blood. https://doi.org/10.1182/blood-2025-3804